Orkid Medilife Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 55.43%
- Profit Growth 33.77%
- Ebitda -42.77%
- Net Worth 42.32%
- Total Assets 48.33%
About Orkid Medilife
Orkid Medilife Private Limited (OMPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 August 2016 (Eight years and five months 25 days old ). Its registered office is in Surat, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dhaval Mangukiya, Odhavji Mangukiya, and Kajal Mangukiya serve as directors at the Company.
Company Details
-
Location
Surat, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85320GJ2016PTC093458
-
Company No.
093458
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Aug 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Orkid Medilife?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhaval Mangukiya
|
Director | 23-Aug-2016 | Current |
|
Odhavji Mangukiya
|
Director | 23-Aug-2016 | Current |
|
Kajal Mangukiya
|
Director | 23-Aug-2016 | Current |
Financial Performance of Orkid Medilife.
Orkid Medilife Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 55.43% increase. The company also saw a substantial improvement in profitability, with a 33.77% increase in profit. The company's net worth Soared by an impressive increase of 42.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Orkid Medilife?
Unlock access to Orkid Medilife's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Sids Health Care Private LimitedDhaval Mangukiya is a mutual person
-
Sanjivani Intensive Care Unit Private Limited
Odhavji Mangukiya is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Orkid Medilife?
Orkid Medilife has a workforce of 16 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orkid Medilife, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orkid Medilife's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.